Objectives: Improvement in localized bone regeneration is needed to avoid the use of autogenous tissue. For that purpose, the use biologic mediators was proposed. The aim was to test whether or not one of two biologic mediators, recombinant human bone morphogenetic protein-2 (rhBMP-2) or recombinant platelet-derived growth factor (rhPDGF-BB), is superior to the other and to control groups for localized bone regeneration.
Various techniques have shown to be successful in augmenting the alveolar ridge prior to implant placement. The most commonly used techniques are the use of autogenous block grafts (Misch et al. 1992; Raghoebar et al. 1996) and guided bone regeneration (Dahlin et al. 1988; Buser et al. 1993; H€ ammerle et al. 1996) . Although these techniques have proven to result in positive clinical outcomes, they are all associated with limitations and drawbacks: for example, like exposure of barrier membranes (Machtei 2001) , an increased risk for infection (Simion et al. 1994) , additional surgical donor site increasing patient morbidity and chair time (Schwartz-Arad et al. 2005) , considerable amount of resorption during the healing process (Donos et al. 2005) , and neurosensory disturbances after the harvesting of either chin or ramus block grafts (Clavero & Lundgren 2003) .
More recently, the tissue engineering principles were used to improve bone regeneration (Gothard et al. 2014) . This field has focused on the investigation of bioactive molecules to induce local bone formation.
The most promising factors for localized ridge augmentation include recombinant human bone morphogenetic protein-2 (rhBMP-2) and recombinant platelet-derived growth factor (rhPDGF-BB) (Jung et al. 2008; Fisher et al. 2013; Khojasteh et al. 2013) . Whereas rh-BMP-2 induces differentiation of osteoblasts precursor cells into more mature osteoblasts-like cells (Yamaguchi et al. 1991) , rhPDGF-BB has a mitogenic function, increasing the quantity of cells.
Pre-clinical models for GBR procedures have been thoroughly evaluated in several studies as "proof-of-principle" (Donos et al. 2015) . This included deproteinized bovine bone mineral (DBBM) (Stavropoulos et al. 2001) , osteoinductive grafts (Mardas et al. 2003a,b,c) , and biological mediators (rhBMP-2 and rhPDGF-BB) (Zellin & Linde 1999; Cochran et al. 2000; Jung et al. 2003; Simion et al. 2006; Hasegawa et al. 2008; Thoma et al. 2010; Darby & Morris 2013) . However, there is a lack of data regarding the comparison between the two biologic mediators and compared to DBBM alone for localized bone regeneration in the same experimental model.
The aim of this study was therefore to test whether or not one of the two biologic mediators (rhBMP-2 or rhPDGF-BB) is superior to the other and to control groups for localized bone regeneration-based histological and microcomputed tomography (micro-CT) outcome measures.
The hypotheses of this study were that the use of biologic mediators is more favorable compared to DBBM alone for localized GBR procedures and that rhBMP-2 and rhPDGF-BB differ in terms of the regenerated area based on histological and micro-CT outcome measures.
Materials and Methods

Animals
The study was designed as a randomized experimental study employing 12 adult (12-month-old) New Zealand white rabbits, weighing between 2.8 and 3.2 kg were used. The animals were kept in a purpose-designed room for experimental animals and were fed a standard laboratory diet. The study was approved by the Institutional Animal Care and Use Committee of Yonsei Medical Center, Seoul, Korea (approval no.:2014-0281) .
Commercially available biological mediators were used. The preparation and the concentration applied were similar to a previous study utilizing rhBMP-2 (Jung et al. 2015) .
Surgical procedure
Anesthesia initiated by injection of 65 mg/ kg of ketamine (Ketalar, Yuhan, Seoul, Korea) and 4 mg/kg of xylazine (Rompun, Bayer Korea, Seoul, Korea). The surgical procedure and the augmentation device have previously been described (Jung et al., 2007) . In brief, a full-thickness flap was elevated to expose the parietal and frontal bones at the cranium. Four slits (7 mm in outer diameter; 1 mm sink depth) and perforations of the external cortical plate were prepared. Subsequently, experimental cylinders made of polycarbonate were screwed in each of the slits obtaining good stability. The dimension of the cylinders was 5 mm in height and 7 mm in outer diameter with a screw design toward the bone site and a small shoulder for a polycarbonate lid toward the covering skin flap.
The following four treatment modalities were assigned to the cylinders ( Fig. 1 For the DBBM/BMP-2 and DBBM/PDGF groups, 0.1 ml of rhBMP-2 (Cowellmedi, Busan, Korea) or rhPDGF-BB (GEM 21S â , Osteohealth, BioMimetic Therapeutics Inc.) at a concentration of 0.1 mg/ml was loaded onto 0.07 g of DBBM granules (BioOss â ; Geistlich Biomaterials), respectively. Ten minutes of binding time was provided for both groups. For the DBBM group, 0.1 ml of saline was mixed with DBBM.
In the first animal, the treatments were randomly assigned to the cylinders. In the subsequently treated animals, the sequence of the treatment modalities was kept but the locations were stepwise rotated in a clockwise direction. The cylinders were left open toward the bone and closed with a lid toward the skin flap. Primary wound closure was obtained. The rabbits were sedated with barbiturates and sacrificed by an overdose of ketamine at 2 weeks (six rabbits) and 8 weeks (six rabbits). The skull containing all four cylinders was removed and placed in 40% ethanol.
Histological preparation
The obtained specimens were dehydrated in a series of graded alcohol solutions and embedded in PMMA (polymethylmethacrylate; Merck AG, Darmstadt, Germany). From each specimen, a longitudinal section through the cylinder of 80-100 lm thickness was obtained by a microcutting and grinding technique (EXAKT â Apparatebau, Norderstedt, Germany) adapted by Donath (Donath & Breuner, 1982) and stained with Hematoxylineosin (H&E).
Histology and histomorphometry
A light microscope (Keyence VHX-S90BE; Keyence Corp., Osaka, Japan) was used.
Computer-assisted histomorphometric measurements were obtained using an automated image analysis system (LAS V4.3; Leica Microsystems, Wetzlar, Germany). One central section of each cylinder was used, assessing the following parameters similar to a previously published study (Jung et al. 2008 ; :
1. the area of bone regeneration (area of bone regeneration [%] = pixel number of the bone area 9 100/total pixel number of the cylinder) (%; AA Histo ); 2. fraction of mineralized bone related to the total area (%; B Histo ); 3. fraction of bone substitute related to the total area (%; BS Histo ); 4. fraction of mineralized tissue (mineralized bone + bone substitute material) related to the total area (%; MT Histo );
5. fraction of non-mineralized tissue related to the total area (%; NMT Histo ).
Radiographic analysis: micro-CT
One examiner, not included in the study design and execution and unaware of the treatment modalities, performed all the measurements. Volumetric evaluations were performed at the harvested specimens with Micro-CT (SkyScan1173; SKYSCAN, Kartuizersweg 3B 2550 Kontich, Belgium) before histological preparation.
Digital microradiographic images were acquired at 130 kVp and 60 lA using 1.0-mm aluminum filtration. Radiation was exposed at the speed of 500 ms on each rotation of 0.2 degrees. High-resolution images were taken with pixel size of 14.91 lm. For image reconstruction, images having 2240 9 2240 pixels were taken by computer software (Nrecon, Bruker-CT, ver.1.5.1.2, Kontich, Belgium). A computer software was used to divide the bone trabecular pattern and marrow cavity for bony structure analysis (Ct Analyzer, Bruker-CT, ver.1.14.4.1). The following parameters were calculated within the cylinders:
1. the area of bone regeneration (%; AA m-CT ); 2. fraction of mineralized bone related to the total area (%; B m-CT ); 3. fraction of bone substitute related to the total area (%; BS m-CT ); 4. fraction of mineralized tissue related to the total area (%; MT m-CT ); 5. fraction of non-mineralized tissue related to the total area (%; NMT m-CT ).
Statistical analysis
The metric variables were described with mean, median, standard deviation, and quartiles. The statistical comparisons of the group mean for the metric variables applied parametric mixed linear models as the data within a rabbit were dependent (clustered). The rabbit was used as random effect in these models. The assumptions of these models were validated qualitatively in view of the small sample sizes. The tests for group mean comparisons were Bonferroni-corrected. The significance level was set at 5%. No correction for the multiple testing of the many parameters was applied also in view of the small sample size. 
Results
The animals did not present weight reduction or signs of local complications during the study period.
Descriptive histology
In all groups with DBBM particles, new bone formation and the bone-to-bone substitute contact increased from 2 to 8 weeks. Outside of the cylinders, in some sites at 2 weeks, and in most sites at 8 weeks, massive new bone formation was evident located on top of the native bone (B) (Figs 2 and 3) . At 2 weeks, in the DBBM/BMP-2 group, few trabecular bone was located close to the native bone (B), whereas the rest of the cylinder was packed with DBBM particles (BS) (Fig. 2a) . At 8 weeks, bone formation filled the entire space between the DBBM particles, reaching every corner of the cylinders. The cylinders were, therefore, densely packed with mineralized tissues (Fig. 3a) .
Bone formation at DBBM/PDGF sites reached a level up to half of the cylinder at 2 weeks (Fig. 2b) . At 8 weeks, bone regeneration partially reached the top of the cylinder, whereas the amount of DBBM particles appeared to be reduced (Fig. 3b) .
In the DBBM group, bone formation reached a level of roughly one-third of the cylinder after 2 weeks (Fig. 2c) . At 8 weeks, bone formation increased with bone reaching the top of the cylinders (Fig. 3c) .
In the control group, bone regeneration was limited to a few trabecular on top of the native bone at 2 weeks (Fig. 2d) . Large parts of the cylinders were filled with non-mineralized tissue. Bone formation increased, mostly along the lateral walls of the cylinder after 8 weeks, but not further coronal than half of the cylinder (Fig. 3d) .
Histomorphometrical analysis
All data are presented in for control with DBBM/BMP-2 group demonstrating statistically significantly greater AA Histo compared to all groups (P < 0.001 vs. DBBM/PDGF, P < 0.001 vs. DBBM, and P < 0.001 vs. control group) (Fig. 4) .
Bone regeneration (B Histo ) at 2 weeks was minimal in all groups, but then increased up to 8 weeks. At 8 weeks, bone regeneration was greatest for DBBM/BMP-2 (35.62% AE 5.06%) with statistically significant differences compared to all other groups (P < 0.001 vs. DBBM/PDGF, P < 0.001 vs. DBBM, and P < 0.001 vs. control group).
The mean values for remaining bone substitute material (BS Histo ) ranged between 31.07% AE 3.55% for DBBM/BMP-2 at 2 weeks and 35.78% AE 2.44% for DBBM/ PDGF at 8 weeks, which was not statistically significant (P > 0.05).
The percentage of MT Histo at 2 weeks ranged between 6.09% AE 4.13% for the control and 47.38% AE 8.32% for the DBBM group, with statistically significant differences between the control group compared to all other groups (P < 0.001). At 8 weeks, the values ranged between 13.37% AE 3.13% for control and 68.08% AE 6.36% for DBBM/BMP-2. All differences between the groups at 8 weeks were statistically significant (P < 0.001) except between DBBM vs. DBBM/ PDGF groups (P = 0.72).
Radiographic analysis: micro-CT
All data are presented in Table 2 .
The mean regenerated area (AA m-CT ) at 2 weeks amounted 43.87% AE 5.53% for DBBM/BMP-2, 42.81% AE 6.46% for DBBM/ PDFG, 48.71% AE 8.07% for DBBM, and 0.96% AE 0.94% for control. The control group demonstrated statistically significantly less AA m-CT compared to all groups (P < 0.001). At 8 weeks, mean AA m-CT values were 63.65% AE 6.1% for DBBM/BMP-2, 50.21% AE 4.34% for DBBM/PDFG, 44.81% AE 3.75% for DBBM, and 4.57% AE 1.88% for control. At 8 weeks, all differences between the groups were statistically significant (P < 0.001) except between DBBM vs. DBBM/ PDGF groups (P = 0.27).
Bone regeneration (B m-CT ) was minimal in all groups, and the percentage of mineralized tissue (MT m-CT ) at 2 weeks ranged between 0.84% AE 0.74% for control and 45.15% AE 5.46% for DBBM, with statistically significant differences between the control group compared to all other groups (P < 0.001). At 8 weeks, all differences between the groups were significantly different (P < 0.001) except between DBBM/PDGF vs. DBBM groups (P = 1.00). 
Discussion
The present experimental study demonstrated that the use of DBBM in combination with rhBMP-2 significantly increased the area of bone regeneration (AA Histo ), the fraction of mineralized bone related to the total area (B m-CT ), and the fraction of mineralized tissue related to the total area (MT m-CT ). The DBBM/PDGF group demonstrated intermediate results between DBBM and DBBM/BMP-2 groups. The descriptive histology revealed that the use of bioactive molecules to induce local bone formation was not only limited to the cylinder itself, but was also observed outside of the cylinder. In the two groups with biologic mediators, the regenerated area within the cylinders reached the top of the cylinder (DBBM/BMP-2) or two-thirds of the cylinder (DBBM/PDGF) at the later time-points. The DBBM group was similar to the two groups with biologic mediators at 2 weeks. At 8 weeks, however, bone formation was limited and similar to the empty control group. In contrast to the groups with biologic mediators, no bone formation was observed outside of the cylinders in groups DBBM and the control group.
For the amount of regenerated area (AA Histo ), the histomorphometric analysis revealed at 2 weeks a similar performance between the groups. However, at 8 weeks, the AA Histo values for DBBM/BMP-2 were statistically significantly greater compared with the other groups, demonstrating almost three times more bone formation compared to the control group and more than two times compared to the DBBM/PDGF group. The micro-CT analysis revealed similar outcomes for the regenerated area (AA m-CT ). The DBBM/BMP-2, DBBM/PDGF, and DBBM groups at 2 weeks rendered similar performance, but at 8 weeks, the groups demonstrated significant differences between each other, and the DBBM/BMP-2 group showed the greatest regenerated area. These favorable outcomes for the use of rhBMP-2 are well in line with a number of previous investigations comparing the same biologic mediator in combination with various graft materials (Zellin & Linde 1999; Cochran et al. 2000; Jung et al. 2003; Thoma et al. 2010) . In terms of rhPDGF-BB, the results were inferior to rhBMP-2 and similar to the control group without the growth factor (DBBM). In an in vitro study, the release of rhPDGF-BB when associated with DBBM+collagen resulted in enhanced proliferation of Significantly different with DBBM/PDGF (P < 0.001).
The area of bone regeneration (AA Histo ); fraction of mineralized bone related to the total area (B Histo ); fraction of bone substitute related to the total area (BS Histo ); fraction of mineralized tissue related to the total area (MT Histo ); fraction of non-mineralized tissue related to the total area (NMT Histo ). Bold indicates significantly different (P < 0.001).
e240 | Clin Oral Impl Res 28, 2017 / e236-e243 osteoblastic cells compared to the carrier alone (Stephan et al. 2000) . This is supported by another in vitro study demonstrating a fast adsorption of rhPDGF-BB to DBBM, and, in the absence of additional proteins competing for adsorption, rhPDGF-BB remained attached (Thoma et al. 2012 ) and active (Stephan et al. 2000) . The lack of collagen with faster degradation, and therefore an early release of biologic mediators, compared to DBBM (Stephan et al. 2000) could explain the slow bone formation at 2 weeks in the present study. The osteoconductive properties of DBBM could also be noted in the present study, corroborating with previous studies that evaluated the capability of DBBM to enhance new bone formation in GBR procedures (H€ ammerle et al. 1995 , 1997 Stavropoulos et al. 2001) .
The fraction of mineralized bone related to the total area (B Histo ) only rendered differences at 8 weeks. The B Histo showed greater values for DBBM/BMP-2 with statistically significant differences compared to all other groups. In the present study, just the control group presented statistically significant differences for the B m-CT at 8 weeks when compared with the others groups. Overall, micro-CT analyses appeared to be less sensitive compared with the histologic analyses. This might be due to the threshold value that was used for the various tissues. Previous studies comparing histologic and micro-CT measurements demonstrated controversial data. One in vitro study showed high correlations between histomorphometric and micro-CT analysis (Thimm et al. 2013) , whereas other stated that to obtain valid conclusions, the analysis should be used in combination (Gielkens et al. 2008) .
The mean values for the fraction of bone substitute related to the total area (BS Histo ) were similar at all time-points, demonstrating that the graft remained stable over the healing period for all augmented groups. When the percentage of mineralized tissue related to the total area was analyzed in both analysis (MT Histo and MT m-CT ), no differences were found between the augmented groups at 2 weeks. Over the course of the following 6 weeks, a large amount of mineralized tissue was formed in the DBBM/BMP-2 group, much greater compared with the other groups. The DBBM/PDGF and DBBM groups rendered only a modest mineralized tissue formation.
There is a lack of data regarding the comparison between rhBMP-2 and rhPDGF-BB for localized bone regeneration in the same experimental model. A study evaluating the efficacy of different concentrations of rhBMP-2 in rabbit calvaria showed a statistically significant difference in amount of newly formed tissue when compared to the control group without rhBMP-2 (Hasegawa et al. 2008) . A study in rabbit mandibles utilizing rhBMP-2 and DBBM showed outcomes in line with the data presented here, with 98% of defect area filled in the rhBMP-2 group (Chen et al. 2007 ), compared to 96.29% in the present study. The use of rhPDGF-BB on the rabbit calvaria in association with DBBM showed a great potential to enhance bone regeneration (Thoma et al. 2012) . Previous studies evaluated the bone regeneration using rhBMP-2 or rhPDGF-BB with different carriers and/or study designs, and also demonstrated positive results in terms of the regenerated area (Wikesj€ o et al. 2004; Miranda et al. 2005; Simion et al. 2007; Jung et al. 2009; Aghaloo et al. 2010; Nevins et al. 2012; Xu et al. 2016) . Although rhBMP-2 demonstrated significantly more bone formation at 8 weeks compared with controls, it is worthwhile to point out the high costs associated with the use of biologic mediators, specifically rhBMP-2. Moreover, rhPDGF-BB is available at a much lower price (accounting for roughly a tenth of the costs for rhBMP-2 produced from eukaryotic system per dose and patient). In the present study, rhBMP-2 produced from E. coli was used, which could yield large quantities at low costs. When roughly calculated, the cost ratio for E. coli-derived rhBMP-2 vs. rhPDGF-BB was 1 : 3 for the same dose. The data indicated that with a third of the costs compared to rhBMP-2, DBBM/PDGF group regenerated 16.91% and 28.87% more bone than DBBM and control groups, respectively. The difference to DBBM/BMP-2 group was 48.15%, thereby leaving room for discussion on the cost-benefit ratio from a clinical point of view.
Whereas the pre-clinical model selected to run this study is well documented (Zellin & Linde 1999; Cochran et al. 2000; Stavropoulos et al. 2001; Mardas et al. 2003a,b,c; Hasegawa et al. 2008; Thoma et al. 2010; Donos et al. 2015) , and has a good acceptance in an ethical point of view, the translation of pre-clinical results should be analyzed with prudence, being an animal model with different physiological responses and metabolism compared to humans. Although the use of small animals, in this case rabbits, significantly differs when compared to clinical trials in humans, this type of study is commonly used as a "proof-ofprinciple." Within the limitations of this study, further pre-clinical and clinical investigations with different and more challenging defects are needed.
Conclusions
The biologic mediator rhBMP-2 was superior compared to rhPDGF-BB and control groups for localized bone regeneration in terms of the amount of regenerated bone and in terms of cost-effectiveness.
